• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

"Ozempic" and Older Adults: Awareness of & Views on Rx Medications for Weight Management


When it comes overweight, obesity, and prescription drugs for weight loss, these results from the National Poll on Healthy Aging suggest older US adults need guidance.

The majority of older US adults, aged 50 to 80 years, have overweight or obesity and most have tried to lose weight using 1 or more popular strategies, according to recent findings published by the National Poll on Healthy Aging. Many of those who report being overweight also agree that they are in fair or poor health.

Nearly 2 in 3 who report being overweight are interested in taking a prescription (Rx) medication to lose weight but the poll found that many older adults are unaware of the range of medications approved for the purpose. Close to two-thirds (61%) had heard of Ozempic, however, and many reported hearing about the class of drugs through advertising and social media, not from their physician.

The slides that follow highlight the rest of the poll's findings and may offer insights about your older adult population.

Findings are from a nationally representative household survey conducted exclusively by NORC at the University of Chicago for the University of Michigan’s Institute for Healthcare Policy and Innovation. The survey was conducted online and by phone July 17th–August 7th, 2023 with a randomly selected, stratified group of US adults aged 50–80 years (n=2,657). The sample was subsequently weighted to reflect population figures from the US Census Bureau.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
Overweight and Obesity: One Expert's 3 Wishes for the Future of Patient Care
Donna H Ryan, MD Obesity Expert Highlights 2021 Research Success and Looks to 2022 and Beyond
Related Content
© 2024 MJH Life Sciences

All rights reserved.